CONTASTA, IDA ANNA
CONTASTA, IDA ANNA
FARMACOLOGIA TRASLAZIONALE - IFT
The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy
2017 Berghella, ANNA MARIA; Contasta, IDA ANNA; Lattanzio, Roberto; Di Gregorio, Giancarlo; Campitelli, Irma; Silvino, Marino; Liberatore Luigi, Liborio; Navarra, Luca; Caterino, Giampaolo; Mongelli, Antonio; Vittorini, Vincenzo; Basta, Matteo; Domenicucci, Mauro; Antonucci, Nunzia; Del Beato, Tiziana; Secinaro, Enzo; Ciccone, Fabiana; Pellegrini, Patrizia
Novel Prognostic Biomarkers for Personalized Cancer Treatment
2015 CONTASTA IDA ; BERGHELLA ANNA MARIA ; LATTANZIO ROBERTO ; CICCARELLI OSVALDO ; DI GREGORIO GIANCARLO ; VIZIOLI MAURIZIO ; SILVINO MARINO ; LIBERATORE LUIGI LIBORIO ; NAVARRA LUCA ; CATERINO GIAMPAOL ; MONGELLI ANTONIO ; VITTORINI VINCENZO ; CAMPITELLI IRMA ; NUNZIA ANTONUCCI ; DEL BEATO TIZIANA ; SECINARO ENZO AND PELLEGRINI PATRIZIA
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age
2014 Berghella A.M.; Contasta I.; Marulli G.; D'Innocenzo C.; Garofalo F.; Gizzi F.; Bartolomucci M.; Laglia G.; Valeri M.; Gizzi M.; Friscioni M.; Barone M.; Del Beato T.; Secinaro E.; Pellegrini P.
A gender-related action of IFNß-therapy was found in multiple sclerosis.
2012 Contasta, I; Totaro, R; Pellegrini, P; DEL BEATO, T; Berghella, Am
Immunological pathways in diagnosis, treatment, cure and prevention of human disease: "Gender-Specific Cytokine Pathways, Targets and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer"
2012 Pellegrini, P; Contasta, I; DEL BEATO, T; Ciccone, F; AND BERGHELLA, Am
Medical research news in the understanding, diagnosis, treatment, cure or prevention of human disease: "Ageing gender-specific targets/biomarkers for the identification of drugs with specific gender-related action and more appropriate therapeutic strategies."
2012 Berghella Anna Maria; Pellegrini Patrizia; Contasta Ida
The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates.
2012 Berghella, Am; Contasta, I; DEL BEATO, T; Pellegrini, P
Medical research news in the understanding, diagnosis, treatment, cure or prevention of cancer disease: "ARE IMMUNOLOGICAL MECHANISMS INVOLVED IN COLON CANCER AND ARE THEY POSSIBLE MARKERS FOR BIOTHERAPY IMPROVEMENT?"
2011 Berghella, ANNA MARIA; Pellegrini, Patrizia; Contasta, IDA ANNA
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy
2011 Berghella, Am; Pellegrini, P; Del Beato, T; Ciccone, F; Contasta, I
Classification of cancer stage using the immune system.
2010 Pellegrini, P; Contasta, I; Berghella, Am; Del Beato, T; Adorno, D
Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients.
2010 Contasta, I; Totaro, R; Berghella, Am; Pellegrini, P; DEL BEATO, T; Carolei, A; Adorno, D
CD30 Molecule, The Immune System and Multiple Sclerosis.
2008 BERGHELLA AM; PELLEGRINI P; CONTASTA I; CAROLEI A; ADORNO D
Are Immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement?
2006 Berghella, Am; Contasta, I; Pellegrini, P; DEL BEATO, T; Adorno, D
Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy
2006 Contasta, I; Pellegrini, P; Berghella, Am; DEL BEATO, T; Adorno, D
The study of patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer.
2006 PELLEGRINI P; BERGHELLA AM; CONTASTA I; DEL BEATO T; ADORNO D.
CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance: The role of IFN beta-1a in the treatment of multiple sclerosis
2005 P a, Pellegrini; R b, Totaro; I a, Contasta; BERGHELLA AM, A; A b, Carolei; D a, Adorno
CD30 Molecule, the Immune System and Multiple Sclerosis. CD30 the still unknown molecule involved in the cell contact-dependent suppression of T cells by dendritic cells, which mediated signals responsible for maintainig the physiological balance between: dendritic and T regulatory cells, the immune responses and central and peripheral tolerance.
2005 Berghella, Am; Pellegrini, P; Contasta, I; Carolei, A; Adorno, D
Immunological mechanisms in the establishment and progression of colon cancer.
2005 Berghella, Am; Pellegrini, P; Contasta, I; DEL BEATO, T; Adorno, D
Immunological mechanisms in the establishment and progression of colon caner
2005 Pellegrini P; Del Beato T; Adorno D; Contasta I; Berghella AM
Immunological study of IFNbeta-1a treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapy
2005 BERGHELLA AM a; TOTARO R b; PELLEGRINI P a; CONTASTA I a; RUSSO T b; CAROLEI A b; ADORNO Da